An industry leader in biopharmaceutical contract manufacturing
Alfa CDMO provides global CDMO services in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs and bispecifics. We offer our partners contract services from DNA to finished drug product. Our technical expertise allows us to provide effective high-quality solutions for our partners biomanufacturing needs. In addition, Alfa CDMO delivers our commitment to our partners through our quality manufacturing, meeting their expectations.
Alfa CDMO strives to be the world leader in providing CRO/CDO services, enabling our clients to deliver top quality biopharmaceuticals to customers globally.
At Alfa CDMO, we believe that our customers are the foundation of our business. We view you not just as customers, but rather as our partners. This is reflected in all parts of our company. Our quality by design approach puts our partners first by ensuring that the project is done correctly and with traceability. We deliver as promised on time at top quality. With this, we believe that the key to our success it to create long-term relationships.
From discussing your project to the final product we keep our partners in mind. All information is kept secure and confidential at every step. Our thoughts are, “how would we like to be dealt with if we were the customer?” We conduct ourselves with honesty in all of our dealings with partners, employees, and the community. Therefore, we deliver on time, quality, and best in value.
Service excellence is reflected in how everyone at Alfa CDMO thinks and acts. From your first interaction with us, you will see us promptly respond, provide consistent communication throughout your project, and a focus on providing a superior experience each and every time. Our quality culture is what drives our commitment to our partners and their biopharmaceuticals.
We continuously improve the quality to provide efficient services, and hope to enable our customers to cooperate with us easily and conveniently.
Based on our profound understanding of biopharmaceutical market, we are committed to the process of delivering top quality solutions globally.